Foot-and-mouth disease virus genome replication is unaffected by inhibition of type III phosphatidylinositol-4-kinases by Loundras, E-A et al.
Downloaded from www.microbiologyresearch.org by
IP:  129.11.23.117
On: Fri, 30 Sep 2016 14:35:51
Foot-and-mouth disease virus genome replication
is unaffected by inhibition of type III
phosphatidylinositol-4-kinases
Eleni-Anna Loundras, Morgan R. Herod, Mark Harris and
Nicola J. Stonehouse
Correspondence
Nicola J. Stonehouse
n.j.stonehouse@leeds.ac.uk
Received 27 January 2016
Accepted 17 June 2016
School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for
Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
Foot-and-mouth disease virus (FMDV) causes economically damaging infections of cloven-
hooved animals, with outbreaks resulting in large financial losses to the agricultural industry. Due
to the highly contagious nature of FMDV, research with infectious virus is restricted to a limited
number of key facilities worldwide. FMDV sub-genomic replicons are therefore important tools for
the study of viral translation and genome replication. The type III phosphatidylinositol-4-kinases
(PI4Ks) are a family of enzymes that plays a key role in the production of replication complexes
(viral factories) of a number of positive-sense RNA viruses and represents a potential target for
novel pan-viral therapeutics. Here, we investigated whether type III PI4Ks also play a role in the
FMDV life cycle, using a combination of FMDV sub-genomic replicons and bicistronic internal
ribosome entry site (IRES)-containing reporter plasmids. We demonstrated that replication of the
FMDV replicon was unaffected by inhibitors of either PI4KIIIa or PI4KIIIb. However, PIK93, an
inhibitor previously demonstrated to target PI4KIIIb, did inhibit IRES-mediated protein translation.
Consistent with this, cells transfected with FMDV replicons did not exhibit elevated levels of
phosphatidylinositol-4-phosphate lipids. These results are therefore supportive of the hypothesis
that FMDV genome replication does not require type III PI4K activity and does not activate these
kinases.
INTRODUCTION
Foot-and-mouth disease virus (FMDV) is the causative
agent of foot-and-mouth disease: a highly contagious, sys-
temic, vesicular infection of domestic and wild cloven-
hooved animals. Major outbreaks in recent years, including
the 2001 outbreak in the UK, resulted in economic losses
estimated at £8 billion (Thompson et al., 2002) and the cull-
ing of millions of livestock to prevent the further spread of
the virus. FMDV replicates rapidly, and therefore can trans-
mit and spread readily, in addition to being able to develop
an asymptomatic carrier state (as reviewed by Alexandersen
et al., 2002). Although vaccines are available, effectiveness
in disease control is hampered by the seven serotypes (and
many sub-types) of FMDV, together with the inability to
distinguish with certainty animals that are vaccinated from
those having recovered from infection (Grubman & Baxt,
2004).
FMDV is a picornavirus in the genus Aphthovirus. It has a
positive-sense ssRNA genome that, upon infection, is trans-
lated into a single polyprotein which is co- and post-transla-
tionally processed. The genome is flanked by 5¢ and 3¢ UTRs
and is polyadenylated. The 5¢ UTR contains a number of
structural regions: a long-hairpin ‘S-fragment’ structure, a
poly-C tract, a region containing pseudoknots, the cis-acting
replicative element (cre) and the internal ribosome entry
site (IRES), involved in 7-methyl-guanosine ‘cap’-indepen-
dent translation (Belsham & Brangwyn, 1990; Martínez-
Salas et al., 2015). The coding region is separated into four
regions: LPro, P1, P2 and P3. LPro encodes a protease that
has been shown to shut off host-cell translation by cleaving
the eIF4G subunit of the host translation initiation machin-
ery (Devaney et al., 1988; Kirchweger et al., 1994). P1 en-
codes the structural capsid proteins. P2 and P3 encode non-
structural proteins including 2C, three 3B proteins (that
encode for the 3 VPg proteins that act as primers for replica-
tion), the 3C protease and the RNA-dependent RNA poly-
merase 3Dpol. This enzyme (in complex with other non-
structural proteins) is involved in replication of the viral
genome (via negative-sense intermediates).
Because of the highly infectious nature of FMDV, handling
is restricted to a small number of facilities worldwide. Sub-
genomic replicons were developed to allow for the study of
viral replication in laboratories at lower containment level
(McInerney et al., 2000). The FMDV replicon constructs
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employed here (pGFP-pac-WT) have the structural proteins
replaced by a GFP reporter and a puromycin acetyltransfer-
ase resistance gene cassette. Replication-deficient constructs
have a GNN mutation in the active site of 3Dpol (pGFP-pac-
GNN). Levels of GFP expression over time can be measured
using an IncuCyte Dual Colour ZOOM FLR (Forrest et al.,
2014; Herod et al., 2015; Tulloch et al., 2014). Replicons
have also been used to study the replication of a number of
other viruses. Here, we have also used hepatitis C virus
(HCV) sub-genomic replicons pSGR-Luc-GFP-JFH-1
(Jones et al., 2007) and SGR-feo-JFH-1 (Wyles et al., 2009),
together with a Coxsackievirus B3 (CVB3) sub-genomic
replicon, pRib-Fluc-CB3/T7 (Lanke et al., 2009).
Replication of a number of positive-sense RNA viruses has
been shown to occur at cytoplasmic membrane-associated
sites (den Boon & Ahlquist, 2010). The formation of such
membrane compartments is thought to allow for the crea-
tion of a kinetically-favourable environment in which
viruses can replicate rapidly and effectively, and to protect
the replication machinery from the hostile environment of
the host cell. Viruses have been shown to subvert mem-
branes of the endoplasmic reticulum (ER), Golgi and trans-
Golgi network (TGN) in order to form these complexes.
Membranes rich in phosphatidylinositol-4-phosphate
(PI4P) lipids have been shown to be required for the repli-
cation of multiple members of the families Picornaviridae
and Flaviviridae, including poliovirus (PV), enterovirus 71,
CVB3, encephalomyocarditis virus (EMCV) and HCV
(Altan-Bonnet & Balla, 2012; den Boon & Ahlquist, 2010;
Dorobantu et al., 2015a). Phosphorylation of phosphatidyl-
inositol (PI) lipids on the 4-carbon of the inositol ring to
generate PI4P is stimulated by the upregulation and selec-
tive recruitment of phosphatidylinositol-4-kinase (PI4K).
There are two types of well-defined families of PI4Ks, type
II (PI4KIIa and PI4KIIb) and type III (PI4KIIIa and
PI4KIIIb). Previous studies on PV and CVB3 have identi-
fied PI4KIIIb as the host enzyme upregulated in viral repli-
cation factories (Arita et al., 2011; Belov et al., 2007; Hsu
et al., 2010; Lanke et al., 2009). Depletion of PI4KIIIb activ-
ity within infected cells by RNA silencing or the use of
kinase inhibitors, such as PIK93 (Knight et al., 2006),
appeared to block PV and CVB3 viral RNA synthesis and
virus replication. In contrast, HCV replication is generally
accepted to be dependent on PI4KIIIa activity (Berger
et al., 2011; Bishe et al., 2012; Reiss et al., 2011), although
there is some evidence for a dependence on PI4KIIIb (Arita
et al., 2011; Borawski et al., 2009; Zhang et al., 2012).
The PI4K family represent a possible pan-viral therapeutic
target, however, involvement in FMDV replication has yet
to be clearly defined. Using bicistronic reporter constructs
and sub-genomic replicons, we have compared the effects
of type III PI4K inhibitors on FMDV with those on other
positive-sense RNA viruses. Using this approach, we have
separated effects on RNA translation from direct effects on
genome replication and show that FMDV replication
appears not to be dependent on this pathway.
RESULTS
The small molecule inhibitor PIK93 inhibits IRES-
mediated translation
Many positive-sense RNA viruses have been documented to
replicate in membrane-associated complexes (den Boon &
Ahlquist, 2010), and there have been several reports dem-
onstrating effects of inhibitors of membrane lipid modifica-
tion, such as PIK93, on viral replication, as described above.
However, in many cases, it has been difficult to separate
effects on translation of input viral RNA from those affect-
ing genome replication. To elucidate effects of PIK93 on
host and viral translation, we exploited the use of bicistronic
vectors containing renilla luciferase (Rluc) and firefly lucif-
erase (Fluc) reporter genes under the control of either cap-
or IRES-dependent translation mechanisms, respectively
(Licursi et al., 2011) (Fig. 1a). We have employed a similar
approach previously to demonstrate the absence of any
non-specific effects on translation with RNA aptamers
selected to FMDV 3Dpol (Forrest et al., 2014).
Five different constructs were used: a control (pRF) with no
IRES structure, resulting in minimal Fluc expression, and
constructs in which Fluc translation was controlled by the
IRES from FMDV, HCV, human rhinovirus (HRV) or
EMCV. The HRV IRES is type I, EMCV and FMDV are
type II and the HCV IRES is classed as a type III (Belsham,
2009; Martínez-Salas et al., 2015; Tsukiyama-Kohara et al.,
1992). For all constructs there was a modest, non-signifi-
cant inhibition of cap-mediated translation in the presence
of an increasing concentration of PIK93 (0–5 µM) (Fig. 1b).
However, the effects of PIK93 on IRES-mediated translation
(Fig. 1c) were more profound. There was a mean decrease
in luciferase signal ranging from 44.2±13.5% in constructs
treated with 1 µM to 73.3±5.0% in those treated with 5 µM
PIK93. Treatment with concentrations higher than 1 µM of
PIK93 significantly reduced FMDV, HCV and EMCV IRES-
driven luciferase expression. However, with the HRV IRES,
a significant reduction in luciferase expression was only
observed at 5 µM PIK93. This effect of PIK93 was not due
to cytotoxicity; MTT assays did not reveal any reduction in
cell viability in the presence of PIK93 at any of the concen-
trations used in the translation assay (Fig. 1d).
This result brings into question whether some of the docu-
mented effects of PIK93 on replication could be the result
of suppression of input viral RNA translation. In order to
clarify this, we compared the effects of PIK93 on the repli-
cation of WT and replication-deficient FMDV replicons
with those on the replication of CVB3, previously shown to
be dependent on PI4K activity (Lanke et al., 2009). Because
of the different reporters used, replication was monitored
by luciferase assay or by GFP expression.
The development of the FMDV GFP-pac replicon and opti-
mization of the replication assay has been described previ-
ously (Forrest et al., 2014). Replication was detected by
measuring the levels of GFP expression over time using an
IncuCyte Dual Colour ZOOM FLR (Tulloch et al., 2014),
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Fig. 1. (a) Schematic of bicistronic reporter constructs. (b, c) Levels of luciferase expression in BHK-21 cells transfected with
bicistronic luciferase reporter constructs. Transfected cells were pre-treated for 2 h with PIK93 at the
concentrations indicated. Levels of luciferase expression were measured at 48 h post-transfection. The effect of PIK93 on (b)
cap-mediated translation and (c) IRES-mediated translation is shown. The control (pRF) contains the firefly reporter under the
control of a non-IRES structure and the renilla reporter under the control of cap-mediated translation. (d) MTT assay of PIK93
on BHK-21 cells shows no cytotoxicity at the concentrations used for functional assays. Data show mean values with SEM
(n=3); statistical analysis was performed using a two-tailed unpaired t-test (*P<0.05, **P<0.01, ***P<0.001,
****P<0.0001). RLU, Relative light units.
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with maximum fluorescence values being observed at 8–
10 h post-transfection. At this time point up to 80% of cells
transfected with the GFP-pac-WT replicon RNA expressed
high levels of GFP, and therefore replication could be
equally assessed by either number of GFP-positive cells or
total GFP fluorescence (data not shown). Use of the replica-
tion-deficient mutant replicon (GFP-pac-GNN) resulted in
a markedly lower GFP signal (i.e. as a result of input trans-
lation only). Levels of GFP expression in GFP-pac-GNN
replicon-transfected cells were similar to those with a sec-
ond replication-deficient replicon, GFP-pac-D3D (Tulloch
et al., 2014), with a large deletion in the 3Dpol gene (data
not shown).
The addition of PIK93 at 2 h pre-transfection resulted in a
dose-dependent reduction in GFP expression in cells trans-
fected with GFP-pac-WT or -GNN replicon RNA (Fig. 2).
Reduction of GFP expression in cells transfected with GFP-
pac-WT ranged from 30.9±6.7% to 50.0±3.9% after treat-
ment with 1 and 5 µM PIK93, respectively, when compared
with untreated control cells (Fig. 2a, b). In GFP-pac-GNN
transfected cells there was a 45.5±2.3% to 69.8±5.2%
reduction (Fig. 2c, d). The reduction in GFP expression in
cells transfected with GFP-pac-GNN in the presence of 5
µM PIK93 (69.8±5.2%) was similar to the decrease
observed in FMDV IRES-mediated translation with the
same concentration of PIK93 (74.1±5.4%).
We then assayed the effects of PIK93 on WT and replica-
tion-deficient CVB3 replicons (Fig. 3). As expected, and in
contrast to the results with FMDV replicons (Fig. 2b),
there was a more pronounced dose-dependent effect of
PIK93 on CVB3 replication. At 5 µM, PIK93 treatment
resulted in a 98.7±0.6% decrease in luciferase expression
in cells transfected with WT Rib-Fluc-CB3/T7 RNA, com-
pared with untreated controls (Fig. 3b). However, cells
transfected with replication-deficient Rib-Fluc-CB3/T7-3A
RNA and treated with 5 µM PIK93 only, exhibited a 38.9
±13.7% decrease in luciferase expression (Fig. 3c), much
less than that seen with FMDV (Fig. 2d). It should be
noted that the genetic backgrounds of the FMDV and
CVB3 constructs are different; however, our data were
consistent with the hypothesis that FMDV genome replica-
tion did not require PI4K activity, and that the effect of
PIK93 was an indirect effect of inhibition of protein
translation.
FMDV replication does not require PI4KIIIa or b
activity
PIK93 was originally developed as an inhibitor of PI3K
(IC50 PI3K p110a: 39 nM), but was shown to have selective
activity against PI4KIIIb (IC50 PI4KIIIa: 1.1 µM, PI4KIIIb:
19 nM) (Knight et al., 2006). Given that some positive-
strand RNA viruses have been shown to require PI4KIIIa
for genome replication (e.g. HCV), it was thus formally
possible that the lack of effect of PIK93 could be explained
if FMDV genome replication exhibited a requirement for
PI4KIIIa but not PI4KIIIb.
We therefore proceeded to directly test if the lack of sensi-
tivity to PIK93 could be explained by a requirement for
PI4KIIIa in FMDV genome replication. To achieve this we
took advantage of two inhibitors developed by AstraZeneca
with complementary selectivities for PI4KIIIa and PI4KIIIb
(Raubo et al., 2015; Waring et al., 2014). CMPD (7) exhibits
selective inhibition of PI4KIIIa (IC50 PI4KIIIa: 7 nM,
PI4KIIIb: 1.8 µM), whereas CMPD (3) exhibits a similar
selectivity to PIK93 (IC50 PI4KIIIa: 7.3 µM, PI4KIIIb: 15
nM). As a positive control for inhibition of PI4KIIIa
we utilized Huh7.5 cells transiently expressing an HCV sub-
genomic replicon (SGR-Luc-GFP-JFH1), derived from the
JFH-1 infectious clone and containing an insertion of GFP
into domain III of NS5A (Jones et al., 2007). This allowed
HCV genome replication to be assayed using the IncuCyte
system, as described for FMDV above.
We first determined whether either compound exhibited
any cytotoxicity in BHK-21 cells (for FMDV experiments)
or Huh7.5 (for HCV). As shown in Fig. 4a, b the com-
pounds were tolerated up to 10 µM by both cell types,
although at 20 µM both exhibited significant cytotoxicity.
We therefore tested the effects of the two compounds on
both FMDV (Fig. 4c) and HCV (Fig. 4d) replication at 0.5
and 10 µM. As shown in Fig. 4c FMDV replication was only
modestly reduced (~20%) by the higher concentration of
both compounds. Reassuringly, whereas CMPD (7) (selec-
tive for PI4KIIIa) inhibited HCV replication even at 0.5
µM (Fig. 4d), CMPD (3) (selective for PI4KIIIb) had no
effect. We deduced that FMDV genome replication is not
dependent on either PI4KIIIa or PI4KIIIb.
FMDV replication does not result in upregulation
of PI4P lipids
It has previously been described (Reiss et al., 2011; Ross-
Thriepland et al., 2015; Zhang et al., 2012) that HCV util-
izes the PI4K pathway to assist in the formation of membra-
nous intracellular replication factories, termed the
‘membranous web’, and consequently the abundance of
PI4P lipids is upregulated during HCV RNA replication.
We predicted that, because we have no evidence that
FMDV replication is dependent on PI4K activity, cells har-
bouring FMDV replicons would not exhibit a similar up-
regulation of PI4P lipids. To test this, we compared the
levels of PI4P lipids in cells harbouring either HCV- or
FMDV- derived replicons. As shown in Fig. 5a, b, Huh7.5
human hepatoma cells harbouring an HCV replicon
showed high levels of PI4P lipids as judged by immunofluo-
rescence analysis using antibodies specific for PI4P (Ross-
Thriepland et al., 2015) that was lost following treatment
with PIK93 and CMPD (7) (selective for PI4KIIIa), consis-
tent with the replication data shown in Fig. 4d.
In contrast, BHK-21 cells transfected with FMDV GFP-pac
RNA did not exhibit an increase in PI4P staining compared
with untransfected cells (Fig. 5c, d). Furthermore, there
were no significant differences in the levels of PI4P staining
in BHK-21 cells after treatment with any of the inhibitors
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tested. We propose that FMDV does not require type III
PI4K activity for genome replication and consequently does
not upregulate activity of these kinases.
DISCUSSION
Phosphatidylinositol lipids (and phosphorylated deriva-
tives) are key membrane components and have been dem-
onstrated to be involved in entry of a number of viruses,
including FMDV (Vazquez-Calvo et al., 2012). Further-
more, the PI4K family of enzymes has been shown to be
involved in the genome replication of many positive-sense
RNA viruses, primarily in the formation of intracellular
membranous compartments by generating PI4P lipids.
These compartments are proposed to house the viral repli-
cation factories to protect the viral RNA from degradation
and recognition by the host cell innate immune response. It
has also been observed that some viruses, such as HCV,
upregulate PI4K expression and activity. PIK93 is a
PI4KIIIb small molecule inhibitor, but has been shown to
have an additional inhibitory effect on PI4KIIIa and PI3K
(Knight et al., 2006; Rutaganira et al., 2016). It has been
demonstrated previously that the treatment of cells with
PIK93 downregulated the generation of PI4P lipids by
inhibiting the activity of PI4KIIIa and b. Furthermore,
studies with HCV, CVB3 and PV have shown that treating
infected cells with PIK93 reduced virus genome replication
(Altan-Bonnet & Balla, 2012). Here, we have demonstrated
that IRES-mediated translation is sensitive to PIK93. There
appears to be an additional effect on genome replication for
CVB3, but not for FMDV.
Consistent with these observations, we found no evidence
(by immunofluorescence microscopy staining for PI4P lip-
ids) that FMDV replication leads to an accumulation of
these lipids. However, in cells electroporated with HCV rep-
licon RNA levels of PI4P were stimulated, as expected.
These data suggest that the PI4K pathway is not the primary
pathway involved with FMDV genome replication.
Membrane reorganization during HCV infection has been
well defined, and it has been reported that PI4KIIIa plays
an essential role in the formation of intracellular replication
factories required for replication. PI3K has also been impli-
cated in HCV replication by recruiting membranous
6
(a)
(c) (d)
(b)
4
2
0
0 2 4 6 8 10 12 14 16 18
6
4
2
0
0
0
0
20
40
60
80
100
1
2 4 6 8 10 12 14 16 18
2 5
0
Time post-transfection (h)
G
F
P
 +
ve
 c
e
lls
 p
e
r 
w
e
ll 
(×
1
0
4
)
G
F
P
 +
ve
 c
e
lls
 p
e
r 
w
e
ll 
(×
1
0
4
)
N
o
rm
al
iz
e
d
 G
F
P
 +
ve
 
c
e
lls
 p
e
r 
w
e
ll 
(%
)
N
o
rm
al
iz
e
d
 G
F
P
 +
ve
 
c
e
lls
 p
e
r 
w
e
ll 
(%
)
Time post-transfection (h)
0
20
40
60
80
100
1
[PIK93] (µM)
0 µM PIK93
1 µM PIK93
2 µM PIK93
5 µM PIK93
0 µM PIK93
1 µM PIK93
2 µM PIK93
5 µM PIK93
[PIK93] (µM)
2 5
Fig. 2. Levels of GFP expression as a measure of replication in BHK-21 cells transfected with (a, b) GFP-pac-WT and (c, d)
GFP-pac-GNN replicon RNAs. Transfected cells were pre-treated for 2 h with PIK93 at the concentrations indicated, and lev-
els of GFP expression were compared against untreated controls. Data were collected by imaging GFP fluorescence hourly in
transfected cells using an IncuCyte Dual Colour ZOOM FLR. Levels of GFP expression 8 h post-transfection are shown in (b)
and (d), and indicated by a dotted line in (a) and (c). Mean values with SEM (n=3) are shown; statistical analysis was performed
using a two-tailed unpaired t-test (**P<0.01, ***P<0.001, ****P<0.0001). +ve, Positive.
http://jgv.microbiologyresearch.org 2225
FMDV genome replication is PI4K-independent
Downloaded from www.microbiologyresearch.org by
IP:  129.11.23.117
On: Fri, 30 Sep 2016 14:35:51
compartments from the endocytic pathway. It has been
demonstrated that FMDV induces the formation of auto-
phagosomes from the endocytic pathway to facilitate cell
entry, but this does not appear to be involved in viral repli-
cation. Autophagosome formation is induced in a PI3K-
independent manner (Berryman et al., 2012), whereas inhi-
bition of both PI3K and PI4KIIIa significantly inhibits
HCV replication in cells (Berger et al., 2009; Gosert et al.,
2003). There is evidence from the literature that reorganiza-
tion of cellular membranes during FMDV infection is dif-
ferent to that seen during infection with other
picornaviruses. FMDV infection results in a dramatic con-
densation and relocalization of intracellular organelles to
one side of the cytoplasm in the perinuclear region (Mona-
ghan, 2004) and is unaffected by brefeldin A, a fungal
metabolite that disrupts retrograde Golgi–ER transport. It
has been shown that brefeldin A interacts with Arf1/GBF1,
and interference with GBF1 affects the recruitment of
PI4KIIIb and subsequent PI4P-lipid upregulation. Interest-
ingly, treatment of cells with brefeldin A has been shown to
enhance FMDV infection (Midgley et al., 2013). Recent
studies have shown that PV, CVB3 and HRV are able to
recruit PI4KIIIb in an Arf1/GBF1-independent manner,
highlighting the complexity of the mechanisms by which
picornaviruses recruit intracellular membranes (Dorobantu
et al., 2015b, 2014; Midgley et al., 2013; O’Donnell et al.,
2001). Overall, these studies support the results shown here
suggesting that type III PI4Ks are not involved in FMDV
replication. It is interesting to note that, during the revision
of this manuscript, a further paper has been published that
supports our conclusions (Berryman et al., 2016). We there-
fore propose that FMDV must subvert an alternative cellu-
lar pathway to effect the membrane reorganization required
to support virus replication.
METHODS
Replicons. Development and use of the FMDV pGFP-pac-WT repli-
con construct has been described previously (Forrest et al., 2014; Tul-
loch et al., 2014). The replication-defective FMDV replicon, pGFP-pac-
GNN, bearing a inactivating point mutation to the 3Dpol active site was
generated by standard PCR mutagenesis (Herod et al., 2015). An HCV
bi-cistronic sub-genomic replicon (pSGR-Luc-GFP-JFH1) (Jones et al.,
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2007) was also employed, where the coding sequence for the structural
proteins (Core, E1 and E2), the viroporin p7 and non-structural protein
NS2 were replaced by a luciferase reporter gene under the translational
control of the HCV IRES, and translation of NS3, NS4A, NS4B, NS5A
and NS5B was driven by the EMCV IRES. A GFP reporter was inserted
into domain III of the NS5A protein; this insertion was tolerated such
that the sub-genomic replicon retained WT replicative ability, as
described previously (Moradpour et al., 2004). A CVB3 sub-genomic
replicon, pRib-Fluc-CB3/T7, was also employed, and a replication-defi-
cient mutant (pRib-Fluc-CB3/T7-3A) was generated by alanine substitu-
tion of residues 6–10, preventing binding of 3A to host-protein GBF1
(Lanke et al., 2009).
Transfection of bicistronic vectors. BHK-21 cells were transfected
with pRF, pRFMDVF, pRHCVF and pREMCVF plasmid DNA using
polyethylenimine (PEI). The DNA : PEI mix was incubated at room
temperature for 10min and supplemented with complete Dulbecco’s
modified Eagle’s medium (DMEM, Sigma) prior to addition to the
cells. After 6 h the media was removed and replaced with complete
DMEM. Cells that were treated with a titration of PIK93 (1–5 µM)
(Sigma) were pre-treated 2 h prior to transfection, and PIK93 was
replaced each time the media was changed.
RNA transcription of replicons. Details of transcription of pGFP-
pac replicons (Tulloch et al., 2014) are described elsewhere (Bentham
et al., 2012; Herod et al., 2015). RNA was purified using a Zymogen
RNA clean and concentrate kit according to the manufacturer’s
instructions. CVB3 and HCV replicons were treated in a similar way.
CVB3 replicon DNA was linearized with MluI (NEB) and HCV repli-
con DNA was first linearized with XbaI (NEB), prior to
transcription.
RNA transfection/electroporation. GFP-pac-WT, GFP-pac-GNN/
D3D and Rib-Fluc-CB3/T7 (-3A) RNAs were transfected into BHK-21
or HeLa cells using Lipofectin (Life Technologies) according to
the manufacturer’s instructions as described by Herod et al. (2015).
PIK93 (1–5 µM), or CMPD (3) or (7) (0.5–20 µM), was added to the
cells 2 h prior to transfection, or at the time of transfection, respectively,
and replaced once the transfection mix was added to the cells. Electropo-
ration of SGR-Luc-GFP JFH-1 RNA into Huh 7.5 cells was undertaken
as described by Ross-Thriepland et al. (2015) and Stewart et al. (2015).
IncuCyte analysis of replication. Expression of GFP in transfected
cells was measured and analysed using an IncuCyte Dual Colour ZOOM
FLR (Essen Bioscience) as described previously (Forrest et al., 2014;
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Fig. 4. MTT assay of (a) BHK-21 cells or (b) Huh7.5 cells treated with either a selective PI4KIIIa inhibitor CMPD (7) or
PI4KIIIb inhibitor CMPD (3) at the concentrations indicated. (c) GFP-pac-WT replicon RNA-transfected BHK-21 cells were
treated with inhibitors as indicated and levels of GFP expression were compared against an untreated control. Levels of GFP
expression were measured at 8 h post-transfection. (d) HCV SGR-Luc-GFP-JFH1 replicon RNA-electroporated Huh7.5 cells
were treated with inhibitors as indicated and levels of NS5A-GFP expression were compared against an untreated control.
Levels of NS5A-GFP expression were measured at 48 h post-electroporation. Data show mean values with SEM (n=3); statis-
tical analysis was performed using a two-tailed unpaired t-test (*P<0.05, **P<0.01). +ve, Positive.
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Herod et al., 2015; Tulloch et al., 2014). After transfection with replicon
RNA, the cells were maintained within an IncuCyte housed at 37

C in a
humidified 5% CO2 incubator. Cells were monitored hourly for up to
20h. Images (9) of each well were taken and the number of GFP-
expressing cells was counted as green object count per well analysed by
an internal algorithm within the IncuCyte ZOOM software.
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Fig. 5. Fluorescence microscopy of (a) Huh7.5 cells stably expressing HCV SGR-Feo-JFH-1 and (c) BHK-21 cells trans-
fected with GFP-pac-WT replicon RNA. Transfected cells were treated with 10 µM CMPD (7), CMPD (3) or 5 µM PIK93.
Fixed cells were stained with anti-PI4P antibody (mouse). NS5A was detected by anti-NS5A antibody (sheep). Untransfected/
non-stably expressing (i.e. naïve) cells were included as controls. Levels of PI4P expression were measured and presented as
total PI4P intensity measured in arbitrary units (a.u.) in (b) Huh7.5 cells and (d) BHK-21 cells. Bars, 20 µm. Data show mean
values with SEM (n=10). Statistical analysis was performed using a two-tailed unpaired t-test (**P>0.01, ****P>0.0001).
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Fluorescence microscopy. Huh 7.5 cells, Huh 7.5 cells stably har-
bouring SGR-feo-JFH-1 (Wyles et al., 2009) (under 0.5 mg ml 1
G418 selection) and BHK-21 cells electroporated with GFP-pac replicon
RNA (following the aforementioned protocols) were incubated in a
humidifying incubator with 5% CO2 for 24 or 4 h, respectively. Cells
were washed, fixed and permeabilized as described previously (Ross-
Thriepland et al., 2015) prior to staining with primary anti-PI4P anti-
body (mouse, 1 : 100; Echelon) and anti-NS5A (sheep, 1 : 2500) with
fluorescently conjugated secondary antibodies – Alexa Fluor 568 rabbit-
anti-mouse and Alexa Fluor 488 donkey-anti-sheep (1 : 1000) (Life
Technologies). Confocal microscopy images were acquired on a Carl
Zeiss 880 upright microscope. Quantification and analysis of the data
was undertaken using integrated Zeiss 2.1 software.
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